Human gene therapy, the public, and public policy.
The public's involvement in the debate over human gene therapy is used to illustrate two points. First, complex bioethical issues often come to the public's attention because of a scandal, in this case the Cline episode; enlightened discussion and public understanding are difficult to achieve under these conditions. Second, even with unfavorable circumstances at the outset, the debate can become channeled into politically responsible institutions which then can develop effective public policy. For gene therapy, four significant forums emerged: the President's Commission's Report Splicing Life, the 1982 Congressional Hearings, the OTA Report, and the RAC's Points to Consider document.
Murray
T H
TH
Center for Biomedical Ethics, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
D026683:Advisory Committees; D004992:Ethics, Medical; D015316:Genetic Therapy; D033161:Government Regulation; D006801:Humans; D028743:Professional Misconduct; D011639:Public Opinion; D011640:Public Policy; D012070:Religion and Science; D018570:Risk Assessment